PATENT CLAIM ANALYSIS

Application Number: 15743560
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The invention provides methods of treating polyglutamine diseases, e.g., spinocerebellar ataxia Type 6, in a subject, comprising administering to the subject an IRES inhibitor in an amount effective for treating the SCA6 in the subject. Also provided herein are the IRES inhibitors, and pharmaceutical compositions comprising the same.

Claim (Index 27):
The recombinant expression vector of any one of  claims 23  to  26 , comprising a woodchuck hepatitis virus posttranscriptional regulatory element (WPRE).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15024492', '15573417', '14011539', '12963793', '15508857']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6908746728652763
- 35 USC 102 Novelty (BERT): 0.5692905249152669
- Combined Prediction Score: 0.6787162580702754
- Mean Citation Score: 302.607136
- Max Citation Score: 497.57776
- Similarity Product: 312.89592340903283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test